Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02410278
What this trial is testing

Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera

Who this might be right for
Multiple Sclerosis
Biogen 102
Testing effectiveness (Phase 2)Study completedNCT04056897
What this trial is testing

Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biocad 271
Not applicableStudy completedNCT03737825
What this trial is testing

Computerized Cognitive Training in MS

Who this might be right for
Multiple SclerosisCognitive Decline
University of California, San Francisco 2
Large-scale testing (Phase 3)Study completedNCT00530348
What this trial is testing

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genzyme, a Sanofi Company 581
Not applicableUnknownNCT03216915
What this trial is testing

Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Universitätsklinikum Hamburg-Eppendorf 100
Post-approval studies (Phase 4)UnknownNCT02769689
What this trial is testing

Methylprednisolone During the Switch Between Natalizumab and Fingolimod

Who this might be right for
Multiple Sclerosis
University Hospital, Clermont-Ferrand 56
Post-approval studies (Phase 4)Study completedNCT00753792
What this trial is testing

Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse

Who this might be right for
Multiple Sclerosis
Germans Trias i Pujol Hospital 49
Post-approval studies (Phase 4)Study completedNCT03784898
What this trial is testing

Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada

Who this might be right for
Multiple Sclerosis
Genzyme, a Sanofi Company 13
Not applicableLooking for participantsNCT05776511
What this trial is testing

Diagnostic Value of eVOG

Who this might be right for
Multiple SclerosisRadiologically Isolated SyndromeWhite Matter Lesions
Centre Hospitalier Universitaire de Nice 150
Not applicableLooking for participantsNCT07230015
What this trial is testing

Combined Motor Imagery and Vestibular Rehab for MS

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
Medipol University 30
Large-scale testing (Phase 3)Looking for participantsNCT07321093
What this trial is testing

The Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Biocad 292
Testing effectiveness (Phase 2)Study completedNCT01093326
What this trial is testing

Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Actelion 353
Not applicableEnded earlyNCT02949908
What this trial is testing

MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 2
Not applicableStudy completedNCT02047825
What this trial is testing

Upper Limbs Intervention in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Universidad de Granada 37
Large-scale testing (Phase 3)Study completedNCT00869726
What this trial is testing

Patients With Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Eli Lilly and Company 596
Testing effectiveness (Phase 2)UnknownNCT02369926
What this trial is testing

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Transparency Life Sciences 20
Not applicableNo Longer AvailableNCT02807285
What this trial is testing

Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Genentech, Inc.
Not applicableUnknownNCT06166043
What this trial is testing

The Effect of the Nurses Support Program on Fatigue in MS Patient

Who this might be right for
Multiple SclerosisFatigueSleep Hygiene+1 more
Istanbul University - Cerrahpasa 30
Very early researchLooking for participantsNCT07337785
What this trial is testing

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Who this might be right for
Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more
Tongji Hospital 36
Not applicableStudy completedNCT05950308
What this trial is testing

Assessment of Immune Response in Multiple Sclerosis Patients With COVID-19/Vaccination Treated With Ofatumumab and Other Disease Modifying Therapies

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 61
Next Page